ACTON, Mass. --(BUSINESS WIRE)--Nov. 9, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences: The
Includes Total Omnipod ® Revenue Growth of 20% ACTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
ACTON, Mass. --(BUSINESS WIRE)--Nov. 2, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced special activities to support its ongoing commitment to
ACTON, Mass. --(BUSINESS WIRE)--Oct. 29, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it is being honored by two Massachusetts agencies for the
ACTON, Mass. --(BUSINESS WIRE)--Oct. 20, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Wayne A. I.
ACTON, Mass. --(BUSINESS WIRE)--Oct. 5, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2020 on
ACTON, Mass. --(BUSINESS WIRE)--Sep. 21, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is commercially launching its Omnipod DASH ® Insulin
ACTON, Mass. --(BUSINESS WIRE)--Aug. 24, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two virtual investor conferences: The Baird 2020 Global
Includes Total Omnipod ® Revenue Growth of 26% ACTON, Mass. --(BUSINESS WIRE)--Aug. 6, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
ACTON, Mass. --(BUSINESS WIRE)--Jun. 29, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2020 on
ACTON, Mass. --(BUSINESS WIRE)--Jun. 24, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its corporate headquarters and manufacturing facility in Acton, MA ,
ACTON, Mass. --(BUSINESS WIRE)--Jun. 11, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its robust schedule of events for the American Diabetes Association
ACTON, Mass. --(BUSINESS WIRE)--Jun. 5, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the
ACTON, Mass. --(BUSINESS WIRE)--May 28, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming virtual investor conferences: The Piper
ACTON, Mass. --(BUSINESS WIRE)--May 12, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), a global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the pricing of its $500 million common stock registered
